Hastie Alex Reid
Transaction: 08/03/2026
OTHER
Change
+54,000
Price
$1.12
Filing
08/05/2026
Type
OTHER
Bionano Genomics, Inc.
BNGO • Medical - Diagnostics & Research
$1.20
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$13.86M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.16Healthy liquidity · 1.98Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:32 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.20
Change0.00%
Shares Out11.55M
Market Cap$13.86M
Enterprise Value$16.33M
52W Range1.00 - 5.50
Beta1.62
P/E-0.43
P/S0.46
P/B0.44
P/FCF-0.68
EV/Sales0.54
Price$1.20
Change0.00%
Shares Out11.55M
Market Cap$13.86M
Enterprise Value$16.33M
52W Range1.00 - 5.50
Beta1.62
P/E-0.43
P/S0.46
P/B0.44
P/FCF-0.68
EV/Sales0.54
EV/EBITDA-0.65
EV/FCF-0.80
Earnings Yield-232.13%
FCF Yield-147.81%
Dividend Yield0.00%
Gross Margin21.95%
Oper. Margin-116.95%
Profit Margin-92.59%
Debt/Eq0.16
Current Ratio1.98
Quick Ratio1.74
Target$46.50
Target Upside3775.00%
Target Median$5.00
Target Range1.00 - 175.00
Volume131.45K
Avg Volume137.99K
EPS Surprise0.05
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.16Healthy liquidity · 1.98Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 7 analyst votes · 2026-09-05
79/100
Bullish
Bullish
4
Hold
3
Bearish
0
Price Target
2026-08-12
Low
$1.00
Mean
$46.50
Median
$5.00
High
$175.00
Insider Transactions
Recent executive and insider activity
OLDAKOWSKI MARK
Transaction: 08/03/2026
OTHER
Change
+15,000
Price
$1.12
Filing
08/05/2026
Type
OTHER
Dixon Jonathan V.
Transaction: 08/03/2026
OTHER
Change
+15,000
Price
$1.12
Filing
08/05/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Hastie Alex Reid | OTHER | +54,000 | $1.12 | 08/03/2026 | 08/05/2026 |
| OLDAKOWSKI MARK | OTHER | +15,000 | $1.12 | 08/03/2026 | 08/05/2026 |
| Dixon Jonathan V. | OTHER | +15,000 | $1.12 | 08/03/2026 | 08/05/2026 |
| Adamchak Mark | OTHER | +5,000 | $1.12 | 08/03/2026 | 08/05/2026 |
| Hastie Alex Reid | OTHER | 0 | Not reported | 07/20/2026 | 07/30/2026 |
| Adamchak Mark | SELL | -7 | $1.30 | 06/03/2026 | 06/03/2026 |
| Chaubey Alka | SELL | -24 | $1.30 | 06/03/2026 | 06/03/2026 |
| OLDAKOWSKI MARK | SELL | -27 | $1.30 | 06/03/2026 | 06/03/2026 |
| Dixon Jonathan V. | SELL | -24 | $1.30 | 06/03/2026 | 06/03/2026 |
| BARKER DAVID L | BUY | +9,149 | $1.19 | 05/14/2026 | 05/14/2026 |
| TWOMEY CHRISTOPHER J | BUY | +9,149 | $1.19 | 05/14/2026 | 05/14/2026 |
| Vuori Kristiina MD | BUY | +9,149 | $1.19 | 05/14/2026 | 05/14/2026 |
| Linney Yvonne | BUY | +9,149 | $1.19 | 05/14/2026 | 05/14/2026 |
| Rajkovic Aleksandar | BUY | +9,149 | $1.19 | 05/14/2026 | 05/14/2026 |
| Holmlin R. Erik | SELL | -51 | $1.10 | 02/17/2026 | 02/18/2026 |
| OLDAKOWSKI MARK | SELL | -20 | $1.10 | 02/17/2026 | 02/18/2026 |
| Dixon Jonathan V. | SELL | -6 | $1.10 | 02/17/2026 | 02/18/2026 |
| Adamchak Mark | SELL | -3 | $1.10 | 02/17/2026 | 02/18/2026 |
| Chaubey Alka | SELL | -18 | $1.10 | 02/17/2026 | 02/18/2026 |
| Holmlin R. Erik | BUY | +69,484 | $1.27 | 02/02/2026 | 02/04/2026 |